198 related articles for article (PubMed ID: 1274591)
1. Liver biopsies from psoriatics related to methotrexate therapy. 2. Findings before and after methotexate therapy in 88 patients. A blind study.
Nyfors A; Poulsen H
Acta Pathol Microbiol Scand A; 1976 May; 84(3):262-70. PubMed ID: 1274591
[TBL] [Abstract][Full Text] [Related]
2. Liver biopsies from psoriatics related to methotrexate therapy. 3. Findings in post-methotrexate liver biopsies from 160 psoriatics.
Nyfors A
Acta Pathol Microbiol Scand A; 1977 Jul; 85(4):511-8. PubMed ID: 899789
[TBL] [Abstract][Full Text] [Related]
3. Liver biopsies from psoriatics related to methotrexate therapy. 1. Findings in 123 consecutive non-methotrexate treated patients.
Nyfors A; Poulsen H
Acta Pathol Microbiol Scand A; 1976 May; 84(3):253-61. PubMed ID: 1274590
[TBL] [Abstract][Full Text] [Related]
4. Methotrexate and liver function: a study of 13 psoriasis cases treated with different cumulative dosages.
Carneiro SC; Cássia FF; Lamy F; Chagas VL; Ramos-e-Silva M
J Eur Acad Dermatol Venereol; 2008 Jan; 22(1):25-9. PubMed ID: 18181969
[TBL] [Abstract][Full Text] [Related]
5. Liver fibrosis in patients with psoriasis and psoriatic arthritis on long-term, high cumulative dose methotrexate therapy.
Lindsay K; Fraser AD; Layton A; Goodfield M; Gruss H; Gough A
Rheumatology (Oxford); 2009 May; 48(5):569-72. PubMed ID: 19273538
[TBL] [Abstract][Full Text] [Related]
6. The role of liver biopsies in psoriatic patients receiving long-term methotrexate treatment. Improvement in liver abnormalities after cessation of treatment.
Newman M; Auerbach R; Feiner H; Holzman RS; Shupack J; Migdal P; Culubret M; Camuto P; Tobias H
Arch Dermatol; 1989 Sep; 125(9):1218-24. PubMed ID: 2774597
[TBL] [Abstract][Full Text] [Related]
7. Short term methotrexate therapy in psoriasis.
Kumar B; Handa S; Kaur I
Indian J Med Res; 1994 Dec; 100():277-80. PubMed ID: 7829167
[TBL] [Abstract][Full Text] [Related]
8. A pilot study of pharmacokinetically guided dosing of oral methotrexate in the initial phase of psoriasis treatment.
Hroch M; Chladek J; Simkova M; Vaneckova J; Grim J; Martinkova J
J Eur Acad Dermatol Venereol; 2008 Jan; 22(1):19-24. PubMed ID: 18031504
[TBL] [Abstract][Full Text] [Related]
9. Liver biopsy in methotrexate-treated psoriatics-a re-evalution.
Zachariae H; Grunnet E; Sogaard H
Acta Derm Venereol; 1975; 55(4):291-6. PubMed ID: 52258
[TBL] [Abstract][Full Text] [Related]
10. Low-dose weekly oral methotrexate therapy for inflammatory arthritis.
Boh LE; Schuna AA; Pitterle ME; Adams EM; Sundstrom WR
Clin Pharm; 1986 Jun; 5(6):503-8. PubMed ID: 3720217
[TBL] [Abstract][Full Text] [Related]
11. Psoriasis-liver-methotrexate interactions.
Arch Dermatol; 1973 Jul; 108(1):36-42. PubMed ID: 4716740
[No Abstract] [Full Text] [Related]
12. Monitoring patients on methotrexate: hepatic fibrosis not seen in patients with normal serum assays of aminoterminal peptide of type III procollagen.
Maurice PD; Maddox AJ; Green CA; Tatnall F; Schofield JK; Stott DJ
Br J Dermatol; 2005 Mar; 152(3):451-8. PubMed ID: 15787813
[TBL] [Abstract][Full Text] [Related]
13. Psoriasis patients with diabetes type 2 are at high risk of developing liver fibrosis during methotrexate treatment.
Rosenberg P; Urwitz H; Johannesson A; Ros AM; Lindholm J; Kinnman N; Hultcrantz R
J Hepatol; 2007 Jun; 46(6):1111-8. PubMed ID: 17399848
[TBL] [Abstract][Full Text] [Related]
14. Longitudinal measurement of methotrexate liver concentrations does not correlate with liver damage, clinical efficacy, or toxicity during a 3.5 year double blind study in rheumatoid arthritis.
Fathi NH; Mitros F; Hoffman J; Straniero N; Labreque D; Koehnke R; Furst DE
J Rheumatol; 2002 Oct; 29(10):2092-8. PubMed ID: 12375317
[TBL] [Abstract][Full Text] [Related]
15. Liver cirrhosis in rheumatoid arthritis patients treated with long-term methotrexate.
Minocha A; Dean HA; Pittsley RA
Vet Hum Toxicol; 1993 Feb; 35(1):45-8. PubMed ID: 8434456
[TBL] [Abstract][Full Text] [Related]
16. Effect of methotrexate therapy in psoriatics on the Ito cells in liver biopsies, assessed by point-counting.
Hopwood D; Nyfors A
J Clin Pathol; 1976 Aug; 29(8):698-703. PubMed ID: 956451
[TBL] [Abstract][Full Text] [Related]
17. Methotrexate hepatotoxicity in psoriatics: report of 104 patients from Nova Scotia, with analysis of risks from obesity, diabetes and alcohol consumption during long term follow-up.
Malatjalian DA; Ross JB; Williams CN; Colwell SJ; Eastwood BJ
Can J Gastroenterol; 1996 Oct; 10(6):369-75. PubMed ID: 9193771
[TBL] [Abstract][Full Text] [Related]
18. Methotrexate hepatotoxicity and concentrations of methotrexate and folate in erythrocytes--relation to liver fibrosis and cirrhosis.
Zachariae H; Schrøder H; Foged E; Søgaard H
Acta Derm Venereol; 1987; 67(4):336-40. PubMed ID: 2445154
[TBL] [Abstract][Full Text] [Related]
19. Short-term methotrexate therapy in psoriasis: a study of 197 patients.
Kumar B; Saraswat A; Kaur I
Int J Dermatol; 2002 Jul; 41(7):444-8. PubMed ID: 12121564
[TBL] [Abstract][Full Text] [Related]
20. Folic acid supplementation during treatment of psoriasis with methotrexate: a randomized, double-blind, placebo-controlled trial.
Salim A; Tan E; Ilchyshyn A; Berth-Jones J
Br J Dermatol; 2006 Jun; 154(6):1169-74. PubMed ID: 16704650
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
